How Temple tackled a leading cause of preventable hospital death
Seventy percent of hospital-acquired venous thromboembolism (VTE) cases are avoidable1 — yet fewer than half of inpatients receive proper preventive measures.2
Temple University Hospital tackled this challenge head-on by standardizing care protocols, adopting new technology and forming an anticoagulation stewardship committee. Their approach significantly lowered VTE rates, which is a leading cause of preventable hospital death in the U.S.3
Learn how to replicate their success with actionable strategies to improve clinical decision-making and patient outcomes in this whitepaper.
Temple University Hospital tackled this challenge head-on by standardizing care protocols, adopting new technology and forming an anticoagulation stewardship committee. Their approach significantly lowered VTE rates, which is a leading cause of preventable hospital death in the U.S.3
Learn how to replicate their success with actionable strategies to improve clinical decision-making and patient outcomes in this whitepaper.
Please fill out the form to download the whitepaper.
1 Smythe MA, Koerber JM, Roberts A, Hoffman JL, Batke J. Hospital Acquired Venous Thromboembolism: A Preventability Assessment. Hosp Pharm. 2024;59(2):183-187. doi:10.1177/00185787231198164
2 Cohen AT, Tapson VF, Bergmann JF, et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study [published correction appears in Lancet. 2008 Jun 7;371(9628):1914]. Lancet. 2008;371(9610):387-394. doi:10.1016/S0140-6736(08)60202-0
3 Joseph Macchiavelli A. Venous Thromboembolism: The Need for Transitions of Care. Med Clin North Am.
2023;107(5):883-894.doi:10.1016/j.mcna.2023.05.001